Ozempic not linked to increase in suicidal thoughts: US study Roshni Dhar12 Jan 2024 4:56 PM ISTA recent U.S. federal study funded by the National Institutes of Health (NIH) and conducted by Case Western Reserve University reveals that...
Health Bulletin 11/January/2024 Roshni Dhar11 Jan 2024 4:47 PM ISTHere are the top health stories for the day:Govt fee for 50 percent MBBS seats in private medical colleges: SC to examine validity of NMC fee orderThe...
Patients to stay on Wegovy longer than older weight loss drugs, expects Novo Nordisk CEO Ruchika Sharma11 Jan 2024 4:30 PM ISTThe Danish drugmaker's chief executive said the effects patients see after being on Wegovy would be an incentive for them to continue, although it may...
Merck seeks GLP-1 drugs with benefits beyond weight loss, says CEO Ruchika Sharma5 Jan 2024 3:36 PM ISTRahway: Merck & Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.Newer...
Novo Nordisk to launch popular anti-obesity drug Wegovy in Japan Ruchika Sharma25 Nov 2023 4:41 PM ISTThe monthly cost for patients will be 7,504 Japanese yen ($50.15) for a 0.25-milligram starter dose and 42,960 yen for a 2.4 mg dose, Novo said.
Wegovy's heart benefits due to more than weight loss: Novo Nordisk Roshni Dhar16 Nov 2023 5:17 PM ISTNovo Nordisk presented groundbreaking data at the American Heart Association meeting, shedding light on the multifaceted cardiovascular benefits of...
Health Bulletin 14/November/2023 Roshni Dhar14 Nov 2023 4:57 PM ISTHere are the top health stories for the day:Medical Council has the power to impose any punishment on doctors as it deems necessary: Delhi HCMedical...
Novo Nordisk, Eli Lilly see insatiable demand for weight loss drugs Ruchika Sharma5 Nov 2023 10:00 AM ISTNovo Nordisk and Eli Lilly both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years - limited only by...
No casual link found between GLP-1 drugs like Novo Nordisk Ozempic, thyroid cancer: EMA Ruchika Sharma29 Oct 2023 12:30 PM ISTThe European Medicines Agency (EMA) has said its safety panel did not find a causal link between popular GLP-1 drugs such as Novo...
Medical Bulletin 07/October/2023 Isra Zaman7 Oct 2023 3:00 PM ISTHere are the top medical news of the day:GLP-1 Agonists, like Ozempic and Wegovy linked to gastrointestinal risks: studyA recent study presented at a...
GLP 1 Agonists, like Ozempic and Wegovy linked to gastrointestinal risks: study Isra Zaman7 Oct 2023 9:00 AM ISTA recent study presented at a medical conference has shown that Glucagon-like peptide 1 (GLP-1) agonists, which are often used off-label for weight...
Novo Nordisk India head eyes 2026 weight-loss drug Wegovy launch Roshni Dhar3 Oct 2023 3:24 PM ISTDanish drugmaker Novo Nordisk aims to bring its blockbuster weight-loss drug Wegovy to India in 2026, after securing regulatory approvals and ensuring...
